Werewolf Therapeutics Files 8-K on Shareholder Vote Matters
Ticker: HOWL · Form: 8-K · Filed: May 28, 2024 · CIK: 1785530
| Field | Detail |
|---|---|
| Company | Werewolf Therapeutics, Inc. (HOWL) |
| Form Type | 8-K |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote, sec-filing
Related Tickers: WERW
TL;DR
Werewolf Therapeutics (WERW) filed an 8-K for a shareholder vote on May 24th.
AI Summary
Werewolf Therapeutics, Inc. filed an 8-K on May 28, 2024, reporting on matters submitted to a vote of security holders as of May 24, 2024. The filing details the company's corporate information, including its principal executive offices in Watertown, Massachusetts.
Why It Matters
This filing indicates that Werewolf Therapeutics held or is holding a vote of its shareholders, which could involve significant corporate decisions or changes.
Risk Assessment
Risk Level: low — This is a routine corporate filing related to shareholder voting and does not appear to contain immediate negative financial or operational news.
Key Numbers
- 001-40366 — SEC File Number (Identifies the company's filing history with the SEC.)
Key Players & Entities
- Werewolf Therapeutics, Inc. (company) — Registrant
- May 24, 2024 (date) — Date of earliest event reported
- May 28, 2024 (date) — Date of report
- 001-40366 (company) — SEC File Number
- 200 Talcott Avenue, 2nd Floor, Watertown, Massachusetts 02472 (location) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of Werewolf Therapeutics' security holders on May 24, 2024?
The filing states that it is a 'Submission of Matters to a Vote of Security Holders' but does not detail the specific proposals in the provided text.
What is the primary business of Werewolf Therapeutics, Inc.?
Werewolf Therapeutics, Inc. is in the 'Pharmaceutical Preparations' industry, SIC code 2834.
Where are Werewolf Therapeutics' principal executive offices located?
The principal executive offices are located at 200 Talcott Avenue, 2nd Floor, Watertown, Massachusetts 02472.
What is the SEC file number for Werewolf Therapeutics?
The SEC file number for Werewolf Therapeutics is 001-40366.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on May 24, 2024.
Filing Stats: 508 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-05-28 16:27:32
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share HOWL The Nasdaq
Filing Documents
- d794252d8k.htm (8-K) — 27KB
- 0001193125-24-148114.txt ( ) — 150KB
- howl-20240524.xsd (EX-101.SCH) — 3KB
- howl-20240524_lab.xml (EX-101.LAB) — 18KB
- howl-20240524_pre.xml (EX-101.PRE) — 11KB
- d794252d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. WEREWOLF THERAPEUTICS, INC. Date: May 28, 2024 By: /s/ Jonathan Owen Jonathan Owen Secretary